This trial will compare the effectiveness of a combination of naltrexone and bupropion medication to placebo in patients with obesity who have not responded to other treatments for binge-eating disorder.
- Binge Eating Disorder
2 Primary · 3 Secondary · Reporting Duration: From post-treatment to the 12-month follow-up
2 Treatment Groups
1 of 2
1 of 2
40 Total Participants · 2 Treatment Groups
Primary Treatment: Naltrexone and Bupropion · Has Placebo Group · Phase 2 & 3
Who is running the clinical trial?
Age 18 - 64 · All Participants · 7 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
What are the effects of Naltrexone and Bupropion?
"Naltrexone and Bupropion is an effective treatment for not just ADHD, but also other disorders such as SAD, smoking cessation, and smoke." - Anonymous Online Contributor
What are the ideal demographics for this clinical trial?
"This study is admitting 40 participants, between the ages of 18 and 64 who currently have binge-eating disorder. It is required that participants also meet the following criteria: BMI 27-30 with a controlled obesity-related co-morbidity; or BMI ≥ 30 and <50, Medically cleared as determined by EKG and medical record review, Able to travel to study location (New Haven, CT) for weekly visits, 18 to 64 years old, Available for the duration of the treatment and follow-up (18 months)." - Anonymous Online Contributor
The age limit for this research is _____ years old, correct?
"The age limit for this clinical trial is 64 years old. As long as participants are over 18 years old, they are eligible for the study." - Anonymous Online Contributor